Abstract
A chiral liquid chromatographic method has been developed for separation of the enantiomers of abacavir sulfate, a nucleoside reverse transcriptase inhibitor for treatment of HIV. The enantiomers were resolved in a Chiralcel OD column with n-hexane–ethanol–trifluoroacetic acid, 92:8:0.1 (v/v), as mobile phase. The resolution between the enantiomers was not less than 3.5. The trifluoroacetic acid had a very important effect on the separation of enantiomers. The method was extensively validated to prove its suitability and robustness. Solution stability and mobile-phase stability were studied for 48 h and found to be stable during this period. The method was found to be suitable for use in quality-control laboratories for analysis of the commercial drug substance.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
